ViewRay Incorporated IPO Research Information

ViewRay Incorporated IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on ViewRay Incorporated, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
ViewRay Incorporated	VRAY - NASDAQ	$12.00-$14.00	$0.00	$0.00	4 million
Underwriter(s): Cowen and Company, Stifel
Co-Manager(s): BTIG, Brean Capital
Industry:
Filing(s): Filed 2015-02-13 Underwriters Added 2015-02-23 Terms Added 2015-03-13

About ViewRay Incorporated (adapted from ViewRay Incorporated prospectus):
They design, manufacture and market MRIdian, the first and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "VRAY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.